FRT
53
3
SRE
61
14
CRM
57
2
MMC
70
2
CF
44
-3
UA
35
-13
UHS
60
-3
BIIB
45
-3
OXY
46
2
MU
56
-3
FMC
31
-3
MCK
73
2
EMC
85
38
MPC
44
5
RL
76
3
FSLR
76
3
MS
70
-2
TSCO
55
2
ALLE
37
-4
EA
47
-3
FRT
53
3
SRE
61
14
CRM
57
2
MMC
70
2
CF
44
-3
UA
35
-13
UHS
60
-3
BIIB
45
-3
OXY
46
2
MU
56
-3
FMC
31
-3
MCK
73
2
EMC
85
38
MPC
44
5
RL
76
3
FSLR
76
3
MS
70
-2
TSCO
55
2
ALLE
37
-4
EA
47
-3
Financhill
Back

Sarepta Therapeutics Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
48

SRPT
Sarepta Therapeutics

Last Price:
131.39
Seasonality Move:
8.89%
Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
41.30
Seasonality Move:
9.35%
Sell
48
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $131.38. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $41.31. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $131.38
    The current trend is moderately bullish and SRPT is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $41.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.14 Buy
Relative Strength Index (14 RSI): 56.17 Buy
Chaikin Money Flow: 32814 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (120.38 - 133.94) Buy
Bollinger Bands (100): (112.94 - 133.06) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.04 Sell
Relative Strength Index (14 RSI): 34.23 Sell
Chaikin Money Flow: -659109 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.82 - 49.38) Sell
Bollinger Bands (100): (49.98 - 66.92) Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 132.21 Sell
20-day SMA: 129.68 Buy
50-day SMA: 126.38 Buy
200-day SMA: 113.51 Buy
8-day EMA: 132.04 Sell
20-day EMA: 130.13 Buy
50-day EMA: 126.92 Buy
200-day EMA: 118.24 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.04 Sell
20-day SMA: 45.31 Sell
50-day SMA: 51.48 Sell
200-day SMA: 51.74 Sell
8-day EMA: 42.54 Sell
20-day EMA: 45.19 Sell
50-day EMA: 50.4 Sell
200-day EMA: 55.58 Sell

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.06 per share, an increase next quarter of $1.31 per share, an increase this year of $6.16 per share, and an increase next year of $6.09 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.88 per share, an increase next quarter of $0.34 per share, an increase this year of $3.60 per share, and an increase next year of $2.16 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):